068 The effective management of idiopathic intracranial hypertension delivered by in-person and virtual group consultations
BackgroundIn response to the rising incidence of IIH and service pressures, we set out to develop a group consultation(GC) service for IIH.MethodIterative, co-designing(with patients) a bespoke GC, i.e. clinical reviews in a group setting. Outcomes measured: patient satisfaction, self-perceived heal...
Saved in:
Published in | Journal of neurology, neurosurgery and psychiatry Vol. 93; no. 6; pp. A121 - A122 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd
01.06.2022
BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
ISSN | 0022-3050 1468-330X |
DOI | 10.1136/jnnp-2022-ABN.393 |
Cover
Summary: | BackgroundIn response to the rising incidence of IIH and service pressures, we set out to develop a group consultation(GC) service for IIH.MethodIterative, co-designing(with patients) a bespoke GC, i.e. clinical reviews in a group setting. Outcomes measured: patient satisfaction, self-perceived health literacy, successful implementation of GC.ResultsEight in-person GCs delivered: once-monthly(Oct-Dec 2019), then twice-monthly(Jan-Feb 2020). Feedback from 49/53: 100% felt more satisfied and heard; 100% felt more involved in decision making; 98% had a better understanding of their condition; 96% felt more able to cope with their condition and keep themselves healthy; 94% rated this as a positive experience; 90% reported improved access and more time with their clinician compared to existing 1:1 appointments.Since Sept 2020 (in response to COVID-19 pandemic) we have delivered once-weekly virtual GC (18 to date). Feedback median scores: patient satisfaction 9.5/10; being listened to by clinician 10/10; involved by clinician in treatment decisions 10/10; clinician explanation of treatment 10/10; opportunity to discuss condition or treatment 10/10).ConclusionsGC is safe and effective for IIH and preferred in our cohort. This allowed ongoing high-quality, person-centred care despite the COVID19 pandemic. We will also share the potential for GC for other neurological conditions.drsuiwong@gmail.com59 |
---|---|
Bibliography: | Live Poster, 13 May | Poster Session 1 ObjectType-Conference Proceeding-1 SourceType-Scholarly Journals-1 content type line 14 |
ISSN: | 0022-3050 1468-330X |
DOI: | 10.1136/jnnp-2022-ABN.393 |